Concepedia

Toshinari Yamashita

TY

71

Publications

10.2K

Citations

31

H-Index

1974

Active since

Affiliations

Kanagawa Prefectural Hospital Organization(Current)

Kanagawa Cancer Center

Aichi Cancer Center

Daiichi Sankyo (United States)

Tokyo Metropolitan Komagome Hospital

Toshinari Yamashita is an author at Kanagawa Prefectural Hospital Organization specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

1974–2025

71

Publications

71

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

Fabrice André, Eva Ciruelos, Gábor Rubovszky et al. · New England Journal of Medicine · 2019 · 2.4K citations · Full text

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.3K citations · Full text

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi, Cristina Saura, Toshinari Yamashita et al. · New England Journal of Medicine · 2019 · 1.9K citations · Full text

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

Fabrice André, Eva Ciruelos, Dejan Juric et al. · Annals of Oncology · 2020 · 557 citations · Full text

Rows per page

1–5 of 71